Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT00560794

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Julius-Maximilians-Universität Würzburg Würzburg, Bavaria, Germany
  • Klinikum der J.W. Goethe Universität Frankfurt am Main, Hesse, Germany
  • Universitätsklinikum Münster Münster, North Rhine-Westphalia, Germany
View Trial Details
Completed

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

NCT00060684

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Greater Baltimore Medical Center Baltimore, Maryland, United States
  • New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

NCT00274742

Conditions
Bites and Stings, Chemically-Induced Disorders, Disease Attributes, +15 more
Locations
  • Medizinische Klinik 5, Hämatologie & Internistische Onkologie, Universitätsklinikum Erlangen Erlangen, Germany
  • Universitätsklinikum Essen, Klinik für Hämatologie, Medizinische Klinik und Poliklinik Essen, Germany
  • Universtätsklinkum Tübingen Tübingen, Germany
  • Universitätsklinikum Ulm, Abteilung Innere Medizin III Ulm, Germany
View Trial Details
Completed

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

NCT00193492

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Integrated Community Oncology Network Jacksonville, Florida, United States
  • Watson Clinic for Cancer Research Lakeland, Florida, United States
View all 22 locations
View Trial Details
Completed

PAD. ICORG 05-01, V11

NCT00814541

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
  • St. James's Hospital Dublin, Ireland
  • University College Hospital Galway, Ireland
View Trial Details

Related conditions